ANDREA YANCEY: Open Payments
NPI 1366080376 · BEAUMONT, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,006 in 54 payments from 11 companies in 2025. Trend: 2023 $1,358 · 2024 $936 · 2025 $1,006
Food & beverage: $1,006
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 15 | $235 |
| Lilly USA, LLC | 13 | $229 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 9 | $161 |
| Tandem Diabetes Care, Inc. | 5 | $114 |
| Radius Health, Inc. | 2 | $72 |
| Sequel Med Tech, LLC | 2 | $54 |
| Amgen Inc. | 3 | $42 |
| Insulet Corporation | 2 | $33 |
| Xeris Pharmaceuticals, Inc. | 1 | $23 |
| Ascendis Pharma Endocrinology Inc | 1 | $22 |
Products named: JARDIANCE, MOUNJARO, Ozempic, t:slim X2 Insulin Pump with Control-IQ, Rybelsus, Tymlos, TWIIST, EVENITY.
Industry payments across TX — which companies pay providers there.
